obesity drug news today october 2025 glp-1 Weight-Loss Demonstration Begins July 2026 Lilly launches GLP-1 pill, kicking

In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium glucose co-transporter 2 (SGLT2) inhibitors compared to patients who received placebo and fatal ketoacidosis has occurred with JARDIANCE

(ii) current contraceptive method

Does retatrutide cause hair loss like some people report on tirzepatide

Hence, no consistent data on differences in adherence between short- and long-acting GLP-1 RAs could be found

Anecdotes abound about Ozempic babieswhen women wound up with unplanned pregnancies while taking both birth-control and the popular GLP-1 drugs for diabetes or weight loss

doi: 10.1056/NEJM199503093321001